United States · FDA National Drug Code directory
Tyvaso DPI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66302-664_81912284-3d3a-430e-a55e-df239b084535
- Product NDC
- 66302-664
- Form
- INHALANT
- Composition / generic term
- treprostinil
- Labeler
- United Therapeutics Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220523
- Source listing expiry
- 20261231
Source-listed ingredients
- TREPROSTINIL — 64 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 BLISTER PACK in 1 KIT (66302-664-03) / 7 BLISTER PACK in 1 BLISTER PACK / 4 INHALANT in 1 BLISTER PACK · 66302-664-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →